Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-01-26 @ 1:07 PM
Study NCT ID:
NCT01834950
Status:
COMPLETED
Last Update Posted:
2018-03-29
First Post:
2013-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Identification of Early Markers of Response and Resistance to Trastuzumab
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer | View |
Keywords: